Works in Neuro-Oncology, 2020, Vol 22, Issue 5


Results: 20
    1
    2

    A randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE).

    Published in:
    Neuro-Oncology, 2020, v. 22, n. 5, p. 705, doi. 10.1093/neuonc/noz232
    By:
    • Cloughesy, Timothy F;
    • Brenner, Andrew;
    • Groot, John F de;
    • Butowski, Nicholas A;
    • Zach, Leor;
    • Campian, Jian L;
    • Ellingson, Benjamin M;
    • Freedman, Laurence S;
    • Cohen, Yael C;
    • Lowenton-Spier, Noa;
    • Minei, Tamar Rachmilewitz;
    • Shmueli, Shifra Fain;
    • Investigators, GLOBE Study;
    • Y, Wen Patrick
    Publication type:
    Article
    3

    Safety and efficacy of VB-111, an anticancer gene therapy, in patients with recurrent glioblastoma: results of a phase I/II study.

    Published in:
    Neuro-Oncology, 2020, v. 22, n. 5, p. 694, doi. 10.1093/neuonc/noz231
    By:
    • Brenner, Andrew J;
    • Peters, Katherine B;
    • Vredenburgh, James;
    • Bokstein, Felix;
    • Blumenthal, Deborah T;
    • Yust-Katz, Shlomit;
    • Peretz, Idit;
    • Oberman, Bernice;
    • Freedman, Laurence S;
    • Ellingson, Benjamin M;
    • Cloughesy, Timothy F;
    • Sher, Naamit;
    • Cohen, Yael C;
    • Lowenton-Spier, Noa;
    • Minei, Tamar Rachmilewitz;
    • Yakov, Niva;
    • Mendel, Itzhak;
    • Breitbart, Eyal;
    • Wen, Patrick Y
    Publication type:
    Article
    4

    Anti–PD-L1 antibody direct activation of macrophages contributes to a radiation-induced abscopal response in glioblastoma.

    Published in:
    Neuro-Oncology, 2020, v. 22, n. 5, p. 639, doi. 10.1093/neuonc/noz226
    By:
    • Ene, Chibawanye I;
    • Kreuser, Shannon A;
    • Jung, Miyeon;
    • Zhang, Huajia;
    • Arora, Sonali;
    • Moyes, Kara White;
    • Szulzewsky, Frank;
    • Barber, Jason;
    • Cimino, Patrick J;
    • Wirsching, Hans-Georg;
    • Patel, Anoop;
    • Kong, Paul;
    • Woodiwiss, Timothy R;
    • Durfy, Sharon J;
    • Houghton, A McGarry;
    • Pierce, Robert H;
    • Parney, Ian F;
    • Crane, Courtney A;
    • Holland, Eric C
    Publication type:
    Article
    5

    INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma.

    Published in:
    Neuro-Oncology, 2020, v. 22, n. 5, p. 684, doi. 10.1093/neuonc/noz222
    By:
    • Bent, Martin Van Den;
    • Eoli, Marica;
    • Sepulveda, Juan Manuel;
    • Smits, Marion;
    • Walenkamp, Annemiek;
    • Frenel, Jean-Sebastian;
    • Franceschi, Enrico;
    • Clement, Paul M;
    • Chinot, Olivier;
    • Vos, Filip De;
    • Whenham, Nicolas;
    • Sanghera, Paul;
    • Weller, Michael;
    • Dubbink, H J;
    • French, Pim;
    • Looman, Jim;
    • Dey, Jyotirmoy;
    • Krause, Scott;
    • Ansell, Pete;
    • Nuyens, Sarah
    Publication type:
    Article
    6
    7
    8
    9

    Highlights from the Literature.

    Published in:
    Neuro-Oncology, 2020, v. 22, n. 5, p. 598, doi. 10.1093/neuonc/noaa069
    By:
    • Popovski, Dean;
    • Huang, Annie;
    • Khasraw, Mustafa;
    • Viapiano, Mariano;
    • Soffietti, Riccardo;
    • Aldape, Kenneth
    Publication type:
    Article
    10

    Forthcoming Meetings.

    Published in:
    Neuro-Oncology, 2020, v. 22, n. 5, p. 737, doi. 10.1093/neuonc/noaa068
    Publication type:
    Article
    11

    Way to Go/No-Go!

    Published in:
    Neuro-Oncology, 2020, v. 22, n. 5, p. 596, doi. 10.1093/neuonc/noaa061
    By:
    • Lesser, Glenn J
    Publication type:
    Article
    12
    13
    14
    15

    Reply to Letter to the Editor.

    Published in:
    Neuro-Oncology, 2020, v. 22, n. 5, p. 734, doi. 10.1093/neuonc/noaa037
    By:
    • Santana-Codina, Naiara;
    • Gonzalez, Josep;
    • Sierra, Angels
    Publication type:
    Article
    16
    17
    18

    Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients.

    Published in:
    Neuro-Oncology, 2020, v. 22, n. 5, p. 601, doi. 10.1093/neuonc/noaa015
    By:
    • Lee, Eudocia Q;
    • Weller, Michael;
    • Sul, Joohee;
    • Bagley, Stephen J;
    • Sahebjam, Solmaz;
    • van den Bent, Martin;
    • Ahluwalia, Manmeet;
    • Campian, Jian L;
    • Galanis, Evanthia;
    • Gilbert, Mark R;
    • Holdhoff, Matthias;
    • Lesser, Glenn J;
    • Lieberman, Frank S;
    • Mehta, Minesh P;
    • Penas-Prado, Marta;
    • Schreck, Karisa C;
    • Strowd, Roy E;
    • Vogelbaum, Michael A;
    • Walbert, Tobias;
    • Chang, Susan M
    Publication type:
    Article
    19
    20